Serological Responses to COVID-19 Vaccines Lower Among Patients with Chronic Liver Disease and CirrhosisMarch 14th 2023
Cirrhosis, older age, and vaccine type were among factors associated with lower antibody responses to COVID-19 vaccines in patients with chronic liver disease, new research shows.
Biden Administration, Others Working Towards Eliminating Hepatitis CMarch 13th 2023
In the White House’s new budget they have put aside several billion dollars towards establishing a hepatitis C (HCV) program. In addition, an HCV vaccine is expected to go into phase 1 clinical trials this year, and a pharmaceutical company is working with states to gain better therapeutic access.
Hepatitis B Vaccine Authorized in Great BritainMarch 7th 2023
The hepatitis B vaccine (Recombinant), Adjuvanted (Heplisav-B) is approved in adults 18 years of age and older, and the vaccine’s developer, Dynavax, is working towards finding potential commercial partners for Great Britain.
1 in 4 Parents Disregarded COVID-19 Safety Procedures for Their ChildrenMarch 6th 2023
The most common reasons parents cited for hiding a child’s COVID-19 infection included an inability to stay home from work and wanting to make decisions about their child’s health without outside input from authorities.
Patient Perspective: Dealing With Recurrent C diffMarch 6th 2023
A young woman who dealt with reoccurring Clostridioides difficile (CDI) in a short amount of time recounts her experience and how getting into a clinical trial made the difference in resolving her condition and getting her back to good health and her family.